We Accept amex

Formerly known as Maylips.com

info@directdoctorsupply.com+1-800-325-7104

Logo Logo
Track delivery Wishlist
  • 0 $ 0.00
  • Products
    • All Products
    • Peptides NEW
    • Anaesthetics
    • Body Sculpting
    • Botulinum Toxin
    • Cannulas and Needles
    • Cellular Rejuvenation
    • Dermal Filler Removal
    • Dermal Fillers
      • Biostimulators
      • HA Dermal Fillers
      • Korean Dermal Fillers
      • Polynucleotides
      • Skinboosters
    • Exosomes
    • Eyelash Enhancers
    • Fat Removal
    • Gynecology
    • Mesotherapy
    • IV Therapy
    • Orthopedic Injections
    • Peels and Masks
    • PRP Kits
    • Skincare
    • Threads
      • PCLA Threads
      • PDO Threads
      • PLA Threads
    • Weight Loss
  • Brands
    • ALIAXIN®
    • ALIDYA™
    • AQUALYX®
    • AZZALURE®
    • BCN
    • BELLAST®
    • BELOTERO®
    • BIOREPEELCL3®
    • BOCOUTURE® (XEOMIN®)
    • BOTOX®
    • CAREGEN
    • CINGAL®
    • CRESPINE®
    • CROMA
    • CYTOCARE
    • DEPO-PROVERA®
    • DERMALAX™
    • DESIRIAL®
    • DUROLANE®
    • DYSPORT®
    • EJAL
    • ELLANSÉ™
    • EMLA™
    • Euflexxa
    • FILLMED®
    • FILORGA®
    • GARDASIL®
    • HArmonyCA™
    • HYACORP
    • HYAFILIA®
    • HYALGAN®
    • HYMOVIS®
    • HYNIDASE®
    • INTRALINE®
    • JALUPRO®
    • JAYDESS®
    • JUVÉDERM®
    • KARISMA
    • LEMONBOTTLE
    • LANLUMA
    • LIPORASE®
    • MEDIDERMA®
    • MESO-RELLE®
    • MESOESTETIC®
    • MICRONJET™
    • MIRENA®
    • MONOVISC®
    • MOUNJARO®
    • NEAUVIA™
    • NEURAMIS®
    • NEXPLANON®
    • NITHYA
    • NOVERA COMPOUNDS
    • NUCLEOFILL™
    • ORTHOVISC®
    • OZEMPIC®
    • PERFECTHA®
    • PLASMOLIFTING™
    • PROFHILO®
    • ​PROSTROLANE®
    • PRX-T33®
    • RADIESSE®
    • RAINBOW
    • REFINE
    • REJURAN®
    • REJUVANAD+
    • REFINE
    • RESTYLANE®
    • REVANESSE®
    • REVOFIL
    • REVOLAX™
    • SAXENDA®
    • SAYPHA®
    • SCULPTRA®
    • SESDERMA®
    • SILHOUETTE
    • SMB®
    • SOFTFIL®
    • STYLAGE®
    • SUNEKOS®
    • SUPARTZ®
    • SYNVISC®
    • T-SAFE®
    • TEOSYAL®
    • ​THERASET®
    • VISCODERM®
    • WEGOVY®
    • XEOMIN®
    • ZO®
  • Peptides NEW
  • Sale
  • Shipping
  • Contact
  • About Us
  • Referral Program
  • Blog
  • Sign In / Register
Logo Logo
Menu
Close
Wishlist
  • Products
    • All Products
    • Peptides NEW
    • Anaesthetics
    • Body Sculpting
    • Botulinum Toxin
    • Cannulas and Needles
    • Cellular Rejuvenation
    • Dermal Filler Removal
    • Dermal Fillers
      • Biostimulators
      • HA Dermal Fillers
      • Korean Dermal Fillers
      • Polynucleotides
      • Skinboosters
    • Exosomes
    • Eyelash Enhancers
    • Fat Removal
    • Gynecology
    • Mesotherapy
    • IV Therapy
    • Orthopedic Injections
    • Peels and Masks
    • PRP Kits
    • Skincare
    • Threads
      • PCLA Threads
      • PDO Threads
      • PLA Threads
    • Weight Loss
  • Brands
    • ALIAXIN®
    • ALIDYA™
    • AQUALYX®
    • AZZALURE®
    • BCN
    • BELLAST®
    • BELOTERO®
    • BIOREPEELCL3®
    • BOCOUTURE® (XEOMIN®)
    • BOTOX®
    • BOTULAX®
    • CAREGEN
    • CINGAL®
    • CRESPINE®
    • CROMA
    • CYTOCARE
    • DEPO-PROVERA®
    • DERMALAX™
    • DESIRIAL®
    • DUROLANE®
    • DYSPORT®
    • EJAL
    • ELLANSÉ™
    • EMLA™
    • Euflexxa
    • FILLMED®
    • FILORGA®
    • GARDASIL®
    • HArmonyCA™
    • HYACORP
    • HYAFILIA®
    • HYALGAN®
    • HYMOVIS®
    • HYNIDASE®
    • INNOTOX®
    • INTRALINE®
    • JALUPRO®
    • JAYDESS®
    • JUVÉDERM®
    • KAIMAX
    • KARISMA
    • LEMONBOTTLE
    • LETYBO®
    • LANLUMA
    • LIPORASE®
    • LIZTOX®
    • MEDIDERMA®
    • MEDITOXIN®
    • MESO-RELLE®
    • MESOESTETIC®
    • MICRONJET™
    • MIRENA®
    • MONOVISC®
    • MOUNJARO®
    • NABOTA® (JEUVEAU®)
    • NEAUVIA™
    • NEURAMIS®
    • NEXPLANON®
    • NITHYA
    • NOVERA COMPOUNDS
    • NUCLEOFILL™
    • ORTHOVISC®
    • OZEMPIC®
    • PERFECTHA®
    • PLASMOLIFTING™
    • PROFHILO®
    • ​PROSTROLANE®
    • PRX-T33®
    • RADIESSE®
    • RAINBOW
    • Re N Tox™
    • REFINE
    • REJURAN®
    • REJUVANAD+
    • REFINE
    • RESTYLANE®
    • REVANESSE®
    • REVOFIL
    • REVOLAX™
    • SAXENDA®
    • SAYPHA®
    • SCULPTRA®
    • SESDERMA®
    • SILHOUETTE
    • SMB®
    • SOFTFIL®
    • STYLAGE®
    • SUNEKOS®
    • SUPARTZ®
    • SYNVISC®
    • T-SAFE®
    • TEOSYAL®
    • ​THERASET®
    • VISCODERM®
    • WEGOVY®
    • XEOMIN®
    • ZO®
  • Peptides NEW
  • Sale
  • Shipping
  • Contact
  • About Us
  • Referral Program
  • Blog
  • Sign In / Register
  • 0 $ 0.00
Direct Doctor SupplyPeptides for ResearchWeight Loss & Metabolic PeptidesCagrilintideCagrilintide 5mg + Semaglutide 5mg
Cag+Sem 10mg Front
Cag+Sem 10mg Back
Cag+Sem 10mg Front
Cag+Sem 10mg Back
ID: 24961
Categories: Cagrilintide, Peptides for Research, Semaglutide, Weight Loss & Metabolic Peptides

Cagrilintide 5mg + Semaglutide 5mg

Brand: NOVERA COMPOUNDS

Strength: 10mg
CAS: Cagrilintide: 1415456-99-3 Semaglutide: 910463-68-2
Chemical Formula: Cagrilintide: C₁₉₄H₃₁₂N₅₄O₅₉S₂ Semaglutide: C₁₈₇H₂₉₁N₄₅O₅₉
Molecular weight: Cagrilintide:4409 g/mol Semaglutide: 4114 g/mol
Peptide Sequence: Cagrilintide: XKCNTATCATQRLAEFLRHSSNNFGPILPPTNVGSNTP Semaglutide: H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-OH
Synonyms: CagriSema
Storage: Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
Shelf life: 24 months from the manufacturing date.

USD
EUR
GBP
$119.00
Contact Us

Cagrilintide + Semaglutide is a dual-agonist combination of an amylin analogue and GLP-1 receptor agonist studied in metabolic and endocrine research. Research suggests that it may produce coordinated effects on appetite regulation, glucose homeostasis, and energy metabolism through simultaneous amylin and GLP-1 receptor activation, enabling investigation of synergistic dual-pathway endocrine signaling, integrated appetite control mechanisms, and metabolic homeostasis in experimental systems.

Disclaimer : Available as lyophilized (freeze-dried) powder for laboratory and in vitro research applications. Reconstitution solution is not included in the pack.

Purity ≥99%

Made in USA

Research Use Only

Fast Shipping

Explore Other High-Purity Peptides

MGF IGF 1Ec 5mg Front

MGF IGF-1Ec 5mg

CJC 1295 5mg Front

CJC-1295 - No DAC 5mg

The Novera Compounds Advantage

Made in the USA

Manufactured in the United States under controlled standards. Reliable production. Dependable supply. No overseas uncertainty.

High Purity — 99% or Better

Every batch meets ≥99% purity specifications and is verified by independent third-party laboratory testing. Clean. Consistent. Documented.

Advanced Lyophilized Stability

Carefully lyophilized for structural integrity and easier handling. No cold shipping required. No dry ice. No complications.

Designed for Research

Ideal for scientific study, analytical testing, and research workflows where consistency and quality matter most.

Smart Pricing. Real Value.

High purity. USA-made. Third-party tested. Priced to make sense.

Everything in One Order

Already ordering other products? Add peptides to the same shipment. One vendor. One contact person. Simple.

Product Description

Specifications

Description

Strength: 10mg
CAS: Cagrilintide: 1415456-99-3 Semaglutide: 910463-68-2
Chemical Formula: Cagrilintide: C₁₉₄H₃₁₂N₅₄O₅₉S₂ Semaglutide: C₁₈₇H₂₉₁N₄₅O₅₉
Molecular weight: Cagrilintide:4409 g/mol Semaglutide: 4114 g/mol
Peptide Sequence: Cagrilintide: XKCNTATCATQRLAEFLRHSSNNFGPILPPTNVGSNTP Semaglutide: H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-OH
Synonyms: CagriSema
Storage: Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
Shelf life: 24 months from the manufacturing date.

Cagrilintide 5mg + Semaglutide 5mg About This Product

Cagrilintide 5mg + Semaglutide 5mg is a research-grade dual-peptide formulation designed for laboratory investigation of metabolic regulation. The combination contains 5mg of cagrilintide, a synthetic 37-amino acid amylin receptor agonist, and 5mg of semaglutide for research, a modified glucagon-like peptide-1 (GLP-1) receptor agonist derived from human GLP-1.

Each component has been independently studied for its proposed role in appetite regulation, glucose control, and gastric motility. Furthermore, the formulation is provided as lyophilized powder in sterile, sealed vials at research-grade purity, designed for laboratory handling and preclinical model development.

  • Peptide Sequence: Cagrilintide: XKCNTATCATQRLAEFLRHSSNNFGPILPPTNVGSNTP | Semaglutide: H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-OH
  • Chemical Formula: Cagrilintide: C₁₉₄H₃₁₂N₅₄O₅₉S₂ | Semaglutide: C₁₈₇H₂₉₁N₄₅O₅₉
  • Molecular Weight: Cagrilintide:4409 g/mol | Semaglutide: 4114 g/mol
  • CAS Number: Cagrilintide: 1415456-99-3 | Semaglutide: 910463-68-2

This combination has been investigated in Phase 3 clinical research for its proposed dual-pathway modulation involving amylin and incretin systems.

Cagrilintide 5mg + Semaglutide 5mg Key Features and Benefits
  • Dual-Peptide Research Formulation — Cagrilintide 5mg + Semaglutide 5mg combination for investigating amylin and GLP-1 receptor signaling in metabolic research
  • Research-Grade Purity — Lyophilized powder verified for composition using high-performance liquid chromatography (HPLC) and mass spectrometry (MS), confirmed ≥98% purity
  • Convenient Laboratory Format — Provided in sterile vials requiring reconstitution with appropriate diluent for use in preclinical research protocols
  • Complementary Mechanisms — Each peptide operates through distinct receptor pathways, allowing researchers to investigate dual-pathway effects on metabolism and appetite regulation
  • Observed Research Applications — Suitable for in vitro cell culture systems, ex vivo tissue models, and animal studies examining coordinated metabolic responses
  • Stable Storage Profile — Lyophilized format maintains peptide stability under standard refrigeration conditions with documented shelf-life
  • Clinical Trial Documentation — Formulation composition matches specifications used in Phase 3 REDEFINE clinical trials
  • For Laboratory Research Use Only — Intended exclusively for regulated research environments and qualified investigators conducting preclinical studies
Cagrilintide 5mg + Semaglutide 5mg Mechanism & Research Applications

The cagrilintide semaglutide combo has been investigated for dual engagement of amylin and GLP-1 signaling pathways. Cagrilintide is an amylin receptor agonist that has been studied for its proposed role in satiety signaling and gastric emptying regulation in appetite control research. Semaglutide is a GLP-1 receptor agonist that has been studied for stimulating glucose-dependent insulin secretion and modulating central appetite regulation pathways.

In Phase 3 clinical research, this combination has been examined for coordinated effects on appetite regulation, glucose metabolism, and metabolic balance. The formulation has been investigated in studies of obesity-related physiology and metabolic dysfunction involving appetite regulation, gastric motility, and postprandial glucose control. Researchers have used this combination to explore how parallel modulation of amylin and GLP-1 receptors may influence metabolic outcomes.

The dual mechanism allows investigation of complementary signaling effects in metabolic systems without requiring separate administration protocols.

Cagrilintide 5mg + Semaglutide 5mg Dosing & Observed Effects in Research

In Phase 3 clinical trials (REDEFINE 1 and REDEFINE 2), the cagrilintide and semaglutide combination was administered once weekly via subcutaneous injection, with dose escalation targeting 2.4 mg of each peptide weekly over a 68-week trial duration.

Observed Effects in Phase 3 Clinical Trials:

REDEFINE 1 Trial (3,417 participants without type 2 diabetes)

  • Mean body weight reduction: 22.7% with combination therapy
  • Achievement of ≥5% body weight reduction: 91.9% (vs. 31.5% placebo)
  • Achievement of ≥20% body weight reduction: >60% of participants
  • Achievement of ≥30% body weight reduction: >20% of participants
  • Improvements noted in body composition, waist circumference, and BMI

REDEFINE 2 Trial (1,206 participants with type 2 diabetes)

  • Mean body weight reduction: 13.7% with combination therapy (vs. 3.4% placebo)
  • Glycated hemoglobin (HbA1c) control: 74% achieved HbA1c ≤6.5%
  • Low incidence of hypoglycemia reported (two severe events in patients on concomitant sulfonylurea therapy)
  • Improvements in cardiometabolic parameters

Gastrointestinal Observations

  • Gastrointestinal adverse events (nausea, vomiting, diarrhea) reported as mostly mild to moderate
  • Injection-site reactions observed in approximately 12% of combination therapy participants (17% with cagrilintide monotherapy)

Notably, these observations derive from Phase 3 human clinical trials with thousands of participants. The 5mg vial formulation described here is designed for preclinical laboratory research and is not intended to replicate therapeutic dosing. The clinical trials used 2.4 mg doses, not the 5mg per peptide in this research vial.

Cagrilintide 5mg + Semaglutide 5mg Storage, Safety & References

Storage Instructions: Store lyophilized vials at 2–8°C, protected from light, in the original packaging. Reconstitute using sterile diluent at neutral pH (6.8–7.2) under aseptic conditions. This CagriSema with 10mg strength is only acceptable under room temperature during transport. Once reconstituted, maintain refrigeration at 2–8°C and avoid freeze-thaw cycles. Use within two weeks of reconstitution.

Laboratory Safety: Use standard laboratory safety practices, including sterile technique and appropriate personal protective equipment (PPE) during handling and reconstitution. Dispose of materials in accordance with institutional biosafety guidelines.

Regulatory Status: CagriSema (cagrilintide-semaglutide combination) NDA was submitted to the FDA in December 2025 for once-weekly treatment of overweight or obesity with weight-related comorbidities. Those who wish to buy semaglutide cagrilintide should know that FDA review is expected in 2026. Moreover, this product is not yet approved for therapeutic use.

References

https://pubmed.ncbi.nlm.nih.gov/40544433/

https://pubmed.ncbi.nlm.nih.gov/37364590/

https://www.nature.com/articles/s41467-025-58680-y

https://pubmed.ncbi.nlm.nih.gov/34289354/

https://pubmed.ncbi.nlm.nih.gov/34288673/

https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2025/07/02/14/43/REDEFINE-1-and-REDEFINE-2

https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916470

Compliance Notice

This product is intended for laboratory research use only and is not approved for human or veterinary use.

Direct Doctor Supply sources its inventory only through authorized distribution channels, so every order arrives sealed in the manufacturer’s original packaging. Our sourcing standards and tracked delivery mean you receive authentic original products every time.

Content prepared by Direct Doctor Supply’s editorial team.

Sourcing and accuracy for this page follow our Editorial Policy: claims are cross-checked against clinical literature, regulatory filings, and manufacturer specifications before anything is published.

SVG Logo Color cropped

info@directdoctorsupply.com

+1-800-325-7104

Book a MeetingTrack delivery
Trustpilot

Supported payment providers

Visa Mastercard American Express Google Pay Apple Pay

*Apple Pay and Google Pay are available via a personalized link provided by your account manager.

🔒 Transactions on this website meet strict PCI DSS compliance for your safety.

Product authenticity guaranteed: all products are sourced from licensed distributors and traceable by LOT number.

Company
  • About Us
  • FAQ
  • Contact Us
  • Referral Program
  • Sitemap
Follow Us
  • Facebook
  • Instagram
  • LinkedIn
Company
  • About Us
  • FAQ
  • Contact Us
  • Referral Program
Follow Us
  • Facebook
  • Instagram
  • Linkedin
Products
  • Anaesthetics
  • Body Sculpting
  • Botulinum Toxin
  • Needles and Cannula
  • Filler Removal
  • Dermal Fillers
  • Eyelash Enhancers
  • Fat Removal
  • Gynecology
  • Mesotherapy
  • Orthopaedic Injections
  • Peels and Masks
  • PRP Kits
  • Skincare
  • Threads
  • Weight Management
Products
  • Anaesthetics
  • Body Sculpting
  • Botulinum Toxin
  • Needles and Cannula
  • Filler Removal
  • Dermal Fillers
  • Eyelash Enhancers
  • Fat Removal
  • Gynecology
  • Mesotherapy
  • Orthopaedic Injections
  • Peels and Masks
  • PRP Kits
  • Skincare
  • Threads
  • Weight Management

All peptide products sold by Direct Doctor Supply are Research Use Only (RUO) and intended solely for laboratory and scientific research. They are not FDA-approved and not for human or veterinary use, clinical, diagnostic, or therapeutic purposes. By purchasing RUO materials, you confirm they will be handled by qualified personnel in a proper research setting and in compliance with regulations. Products must not be administered to humans or animals or represented as safe or effective for medical use. Use is at your own risk; Direct Doctor Supply assumes no liability for misuse or regulatory issues.

2026 Direct Doctor Supply All rights reserved.
Terms Of Use Privacy Policy Refund and Replacement Shipping & Delivery
13159_NOVERA_COMPOUNDS_LLC_Semaglutide_5mg-Cagrilintide_5mg.pdf

We'll send the lab results to this email address.